Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026
Go back to Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026| (NASDAQ: VYGR) | Delayed: 3.77 +0.05 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.72 | 52 Week High | $30.54 | |||
| Open | $3.67 | 52 Week Low | $8.12 | |||
| Day High | $3.78 | P/E | N/A | |||
| Day Low | $3.67 | EPS | $0.00 | |||
| Volume | 187,720 | |||||
